Malá molekula (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malá molekula" in Czech language version.

refsWebsite

Global rank Czech rank

2^nd place

4^th place

4^th place

8^th place

3^rd place

25^th place

11^th place

313^th place

18^th place

99^th place

books.google.com

Macielag MJ. Antibiotic Discovery and Development. Redakce Dougherty TJ, Pucci MJ. [s.l.]: [s.n.], 2012. ISBN 978-1-4614-1400-1. Kapitola Chemical properties of antibacterials and their uniqueness, s. 801–2.
Samanen J. Introduction to Biological and Small Molecule Drug Research and Development: theory and case studies. Redakce Ganellin CR, Jefferis R, Roberts SM. Kindle. vyd. New York: Academic Press, 2013. ISBN 978-0-12-397176-0. doi:10.1016/B978-0-12-397176-0.00005-4. Kapitola Chapter 5.2 How do SMDs differ from biomolecular drugs?, s. 161–203.

Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Reviews Drug Discovery. April 2004, s. 301–17. doi:10.1038/nrd1343. PMID 15060526. S2CID 13879559.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.. June 2002, s. 2615–23. doi:10.1021/jm020017n. PMID 12036371.
Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. December 2004, s. 337–341. doi:10.1016/j.ddtec.2004.11.007. PMID 24981612.
Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. November 2007, s. 881–90. doi:10.1038/nrd2445. PMID 17971784. S2CID 205476574.
Samanen J. Introduction to Biological and Small Molecule Drug Research and Development: theory and case studies. Redakce Ganellin CR, Jefferis R, Roberts SM. Kindle. vyd. New York: Academic Press, 2013. ISBN 978-0-12-397176-0. doi:10.1016/B978-0-12-397176-0.00005-4. Kapitola Chapter 5.2 How do SMDs differ from biomolecular drugs?, s. 161–203.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010, s. 100. doi:10.1038/ncomms1093. PMID 20981028. Bibcode 2010NatCo...1..100W.

Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010, s. 100. doi:10.1038/ncomms1093. PMID 20981028. Bibcode 2010NatCo...1..100W.

Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Reviews Drug Discovery. April 2004, s. 301–17. doi:10.1038/nrd1343. PMID 15060526. S2CID 13879559.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem.. June 2002, s. 2615–23. doi:10.1021/jm020017n. PMID 12036371.
Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. December 2004, s. 337–341. doi:10.1016/j.ddtec.2004.11.007. PMID 24981612.
Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. November 2007, s. 881–90. doi:10.1038/nrd2445. PMID 17971784. S2CID 205476574.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010, s. 100. doi:10.1038/ncomms1093. PMID 20981028. Bibcode 2010NatCo...1..100W.

Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Reviews Drug Discovery. April 2004, s. 301–17. doi:10.1038/nrd1343. PMID 15060526. S2CID 13879559.
Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. November 2007, s. 881–90. doi:10.1038/nrd2445. PMID 17971784. S2CID 205476574.